Business Wire

MA-PRECISELY

3.11.2022 14:01:44 CET | Business Wire | Press release

Share
UK Police Force Leverages Location Intelligence from Precisely to Keep World Leaders Safe at Global Summit

Precisely, the global leader in data integrity, today announced that Devon and Cornwall Police leveraged its GIS software to enhance safety measures during the 2021 G7 Summit – the annual gathering of policy leaders from seven of the world’s major democracies. The local police force combined MapInfo Pro with third-party 3D visualizations to create a digital twin that enabled precise contingency planning – based on a model that had an accuracy of up to five millimeters.

The innovative use of geospatial solutions, alongside cutting-edge 3D technology, has huge implications for security and event planning. Mounting geopolitical tension is increasing the likelihood of security threats, meaning that high profile events, such as Queen Elizabeth II’s recent funeral procession, are requiring unprecedented levels of complex security protocol. The pandemic has also made contingency planning more challenging by limiting the ability to bring together large groups of people to do in-person planning.

“We had two major hurdles we had to cross during the planning phase for the G7 Summit,” said Robert Goldsmith, GIS and Mapping Manager, Devon and Cornwall Police. “The first challenge was managing the sheer volume of security protocols needed for such a high-profile event, particularly given that the Summit was hosted in two locations. This meant that safety measures were required for different venues, as well as for each of the world leaders, as they travelled back and forth. The second was giving visibility to our security partners around the world, especially as the pandemic limited the ability for teams to travel to the site in the run up to the event.”

The force’s GIS team quickly recognized that mapping software could play an important role to easily bring together data from a variety of sources and data formats, providing critical context in the assessment of all safety protocols leading up to and throughout the Summit. As an existing Precisely customer, Devon and Cornwall Police leveraged MapInfo Pro, a powerful desktop mapping solution that unlocks location-based context from data, empowering confident decisions grounded in visualizations of data patterns that would otherwise be hidden.

Goldsmith and his team used MapInfo Pro to generate 2D gridded map books of the venues and enriched it with points of interest (POI) data, such as foot bridges, cell masts, bus stops, and officer and partner locations. External datasets from other GIS units were also fed into the solution to seamlessly connect different formats for maximum context.

The 2D mapping created in MapInfo Pro proved to be the ideal foundation for the team to create cutting edge 3D visualizations. Leveraging capabilities provided by third-party providers, the team used aerial drone footage to build out an initial model. This was further augmented with 360-degree visualizations, using video footage that was meticulously captured by scanning over 140,000 square meters of the Summit venues.

The result was a hyper-accurate virtual representation, or digital twin, of the entire area. This enabled Devon and Cornwall Police and their partners, to anticipate security issues and create contingency plans using virtual reality headsets to remotely access locations during the planning phase. This removed the need to have more individuals on the ground than necessary in the run up to the event, while still enabling highly accurate contingency planning to take place.

“The data was accessible by our partners who could view our venues from any phone, tablet, or laptop, anywhere in the country,” said Goldsmith. “These insights benefitted a wide range of stakeholders such as our firearms, ops planning, and counter drone teams, and even external partners including the U.S. Secret Service, because they were able to understand the risks and opportunities different locations and routes presented.”

The G7 Summit went off without security hitch, with the GIS technology widely credited as being central to its success.

“Location intelligence is a crucial element of data integrity, allowing customers to unlock essential context from their data,” said Clarence Hempfield, Senior Vice President – Product Management at Precisely. “Working with Devon and Cornwall police allowed us to see our solutions in action, alongside third-party technology, to help enhance security at an internationally renowned event involving some of the world’s top leaders. We are incredibly proud to fuel organizations across the globe with the trusted data they need to confidently make critical decisions that better serve and protect their citizens.”

Learn more about how Devon and Cornwall Police used location intelligence for the G7 Summit planning here.

About Precisely

Precisely is the global leader in data integrity, providing accuracy, consistency, and context in data for 12,000 customers in more than 100 countries, including 99 of the Fortune 100. Precisely’s data integration, data quality, data governance, location intelligence, and data enrichment products power better business decisions to create better outcomes. Learn more at www.precisely.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221020006182/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye